Atheroschlerosis risk factors

Pharmacology and Therapeutics

Volumn 32, Issue 3, 1987, Pages 207-235

  Kannel, W B ^a   Sytkowski, P A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL;

ARTERIOSCLEROSIS; HUMAN; RISK FACTORS;

EID: 0023244603     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(87)90075-1     Document Type: Article

References (219)

1. Committee on Food and Nutrition Position statement on diet and coronary heart disease
2. Workshop Report. Conference on the health effects of blood lipids: Optimal distributions for populations
3. Committee Report Risk factors and coronary disease A statement for physicians
4. Cholesterol-lowering diets. Experimental trials and literature review
5. Long-term effects of high-carbohydrate, high-fiber diets on glucose and lipid metabolism: a preliminary report on patients with diabetes
6. Cold snaps, snowfall and sudden death from ischemic heart disease
7. NIH release first data from lipid research clinic program
8. Regression of atherosclerosis
9. Relation of weight change to changes in atherogenic traits: The Framingham Study
10. Ischemic heart disease in women. A study based on a randomized population sample of women and women with myocardial infarction
11. Royal College of General Practioners' Oral Contraception Study: Mortality among oral-contraceptive users
12. Social networks, host resistance, and mortality: A nine-year follow-up study of Alameda county residents
13. Coronary risk factors. How to evaluate and manage them
14. How nutrition influences mass hyperlipidemia and atherosclerosis
15. End results cost and productivity of coronary-care units
16. The genetic determinants of coronary artery patterns: a possible factor in atherogenesis
17. HDL dependent elimination of cholesterol from human arterial tissue
18. Multivariate prediction of coronary heart disease in the Western Collaborative Group Study compared to the findings of the Framingham Study
19. Alcoholic heart disease
20. Oestrogen content of oral contraceptives (Letter)
21. Alcoholic cardiomyopathy
22. A mechanism by which high-density lipoproteins may slow the atherogenic process
23. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study
24. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
25. The filter cigarette and coronary heart disease: The Framingham Study
26. Why hypertension is so prevalent in the elderly—and how to treat it
27. A study of atherosclerosis regression in Macaca Mulatta IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl
28. Oral contraceptives and hypertension. An epidemiological survey
29. Oral contraception and increased risk of cerebral ischemia or thrombosis
30. The decline in mortality from coronary heart disease, USA 1968–1975
31. Hypertension, oral contraceptive agents and conjugated estrogens
32. Mortality and hardness of local water supplies
33. Dietary cholesterol is co-carcinogenic for colon cancer
34. Cardiovascular disease among problem drinkers
35. Oral contraceptives and cardiovascular disease
36. Environmental factors in hypertension
37. Familial aggregation of factors assoicated with coronary heart disease
38. Urinary sodium, potassium and creatinine excretion in hypertensive and normotensive Australians
39. Alcohol consumption, cardiovascular risk factors and mortality in two Chicago epidemiologic studies
40. Why the American decline in coronary heart disease?
41. Regression and ANOVA with Zero-one data Measrues of residual variation
42. Cardiac resuscitation and the community
43. Long-term survival after out-of-hospital cardiac arrest
44. Dietary fat and cancer trends—a critique
45. Hereditary aspects of coronary heart disease
46. Hyperglycemia. A risk factor in coronary heart disease
47. Predicting, explaining and preventing coronary heart disease. An epidemiological view
48. Plasma glucose levels: long-term effect of diet in the Chicago Coronary prevention Evaluation Program
49. On a possible inverse relationship between serum cholesterol and cancer mortality
50. Oral contraceptives and blood pressure
51. Salt, volume and the prevention of hypertension
52. Sounding Board. Should mild hypertension be treated?
53. A psychological questionnaire predictive of myocardial infarction: Results from the Kaiser-Permanente Epidemiologic Study of Myocardial Infarction
54. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico
55. Increase in deaths from ischaemic heart-disease after blizzards
56. Physiological role of lecithin-cholesterol acyltransferase
57. Classification and diagnosis of hyperlipoproteinemia
58. Dietary fat and atherosclerosis
59. Diet-coronary heart disease relationships reconnoitered
60. Sounding Board. Diet and coronary heart disease: another view
61. High density lipoprotein cholesterol and incidence of coronary heart disease—the Israeli Heart Disease Study
62. Obesity and cardiovascular diseases. The Framingham Study
63. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application
64. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham Study
65. Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico
66. Lipoproteins, cardiovascular disease and death: The Framingham Study
67. Predictability of coronary heart disease
68. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham Study
69. Is atherosclerosis reversible
70. Oral contraceptives and hypertension. A report from the Boston Collaborative Drug Surveillance Program
71. Is atheroma reversible lesion?
72. Hereditary aspects of coronary artery disease
73. Evans County cardiovascular and cerebrovascular epidemiologic study Introduction
74. The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease
75. Daily alcohol consumption and fatal coronary heart disease
76. Possible roles of dietary fats in carcinogenesis
77. Primary prevention of the atherosclerotic diseases
78. Circulating cholesterol level and risk of death from cancer in men aged 40–69 years Experience of an international collaborative group
79. Oral contraceptives and stroke in young women: a clinicopathologic correlation
80. Diabetes and the heart: coronary heart disease
81. Psychologic and social precursors of coronary disease
82. Psychologic and social precursors of coronary disease
83. Recent evidence supporting psychologic and social risk factors for coronary disease
84. Recent evidence supporting psychologic and social risk factors for coronary disease
85. Myocardial infarction and other vascular diseases in young women. Role of estrogens and other factors
86. Serum cholesterol and mortality in a Japanese-American population: The Honolulu Heart Program
87. Role of blood pressure in cardiovascular disease: The Framingham Study
88. Update on the role of cigarette smoking in coronary artery disease
89. Obesity and cardiovascular disease: The Framingham Study
90. Evaluation of cardiovascular risk in the elderly: The Framingham Study
91. Physiological and medical concomitants of obesity
92. Diabetes and cardiovascular risk factors: The Framingham Study
93. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study
94. Diabetes and cardiovascular disease: The Framingham Study
95. Hypertension in Framingham
96. Some health benefits of physical activity: The Framingham Study
97. Implications of the recent decline in cardiovascular mortality
98. Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Framingham Study
99. Factors of risk in the development of coronary heart disease—six-year follow-up experience: The Framingham Study
100. Perspectives on systolic hypertension. The Framingham Study
101. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: The Framingham Study
102. Hemoglobin and the risk of cerebral infarction: The Framingham Study
103. Role of diabetes in congestive heart failure: The Framingham Study
104. Menopause and risk of cardiovascular disease: The Framingham Study
105. Labile hypertension: A faulty concept? The Framingham Study
106. Coronary heart disease—the global picture
107. Overweight and the risk of heart attack and sudden death
108. Alcohol consumption and blood pressure Kaiser-Permanente Multiphasic Health Examination Data
109. Alcohol consumption before myocardial infarction
110. The Yugoslavia cardiovascular disease study. II. Factors in the incidence of coronary heart disease
111. The increasing mortality attributed to cirrhosis and fatty liver in Baltimore: 1957–1966
112. The inverse relation between fish consumption and 20-year mortality from coronary heart disease
113. Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study
114. Electrolytes and hypertension
115. Prospective and retrospective studies of coronary heart disease
116. Variations in mortality by weight among 750,000 men and women
117. The human fog: cancer and cholesterol
118. The coronary care unit New perspective and directions
119. Blood pressure in Melanesians
120. Comparison of the effects of pharmacological theraphy and a low-sodium diet on mild hypertension
121. Risk factors for myocardial infarction in young women
122. Oral contraceptive use in older women and fatal myocardial infarction
123. Blood chemistry and lipid profiles of elite distance runners
124. Cerebrovascular diseases associated with the use of oral contraceptives. A review of the English-language literature
125. Competitive drive, pattern A, and coronary heart disease: a further analysis of some data from the Western Collaborative Group Study
126. The epidemiology and pathology of sudden fatty liver deaths
127. The probability of developing certain cardiovascular diseases in 8 years at specified values of some characteristics
128. The Framingham Study applied to four other U.S. based epidemiological studies of cardiovascular disease
129. Fats and atheroma: an inquest
130. Myocardial infarction over a five-year period. I. Prevalence, incidence and mortality experience
131. New weight standards for men and women
132. Recent trends in mortality from cardiovascular diseases
133. Plasma high-density-lipoprotein concentration and development of ischaemic heart disease
134. The Tromso Heart Study. High-density lipoprotein and coronary heart disease: A prospective case-control study
135. Relationship between serum cholesterol and body fatness. An epidemiologic study
136. Hypertension treated by salt restriction
137. Interrelationship in humans between sodium intake and hypertension
138. Hardness of local water supplies and mortality from cardiovascular disease in the County Boroughs of England and Wales
139. Blood pressure responses to extremes of sodium intake in normal man
140. Can epidemiology elucidate the water study?
141. Autopsy comparison of cardiovascular changes in castrated and normal women
142. Effect of bilateral ovariectomy on coronary-artery disease and serum lipid levels
143. Blood pressure, Sodium intake and sodium related hormones in the Yanomamo Indians, a “no-salt” culture
144. Epidemiology of stroke in an elderly welfare population
145. Physical activity as an index of heart attack risk in college alumni
146. Epidemiologic evidence on the etiology of human hypertension and its possible prevention
147. Antecedents of cardiovascular disease in six Solomon Islands societies
148. Moderate sodium restriction and diuretics in the treatment of hypertension
149. Use of oral contraceptives, cigarette smoking and risk of subarachnoid haemorrhage
150. Clinical toxicity of reserpine in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program
151. Adverse reactions to practolol in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Progam
152. Frequency of coronary heart disease and cerebrovascular accidents in parents and sons of coronary heart disease index cases and controls
153. Relationship of blood pressure serum cholesterol smoking habit relative weight and ECG abnormalities to incidence of major coronary events Final report of the Pooling Project
154. Sodium intake and blood pressure in two Polynesian populations
155. The Tokelau Island migrant study
156. Acute myocardial infarction in toxic cardiomyopathy without coronary obstruction
157. Evidence for cardiomyopathy in familial diabetes mellitus
158. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients
159. Obesity: Its risks and hazards
160. Coronary artery disease and its risk factors in families of young men with angina pectoris and in controls
161. Gonadal function and the development of coronary heart disease
162. The genetic component in coronary heart disease—a review
163. Increased incidence of coronary heart disease in women castrated prior to the menopause
164. Associations of coronary and stroke mortality with temperature and snowfall in selected areas of the United States, 1962–1966
165. Plasma lipids and mortality: a source of error
166. Early menopause and the risk of myocardial infarction
167. Coronary heart disease in the Western Collaborative Group Study: Final follow-up experience in 8 1/2 years
168. Multivariate prediction of coronary heart disease during 8.5 years follow-up in the Western Collaborative Group Study
169. A new type of cardiomyopathy associated with diabetic glomerulosclerosis
170. The pill and hypertension
171. High blood pressure and the salt intake of the Japanese
172. Lipoprotein apoprotein metabolism
173. Causes of death of alcoholics
174. Relation between mortality from Cardiovascular disease and treated water supplies Variations in states and 163 largest municipalities of the United States
175. Cadmium, chromium, and cardiovascular disease
176. Increased coronary mortality in relatives of hypercholesterolemic school children: The Muscatine Study
177. Oral-contraceptive use in relation to myocardial infarction
178. Water constituents and trace elements in relation to cardiovascular disease
179. Hostility, risk of coronary heart disease, and mortality
180. Diet, serum cholesterol and death from coronary heart disease. The Western Electric study
181. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18 year follow-up
182. Relationship of blood pressure to sodium excretion in a population survey
183. Epidemiological studies in a total highland population, Tukisenta, New Guinea. Cardiovascular disease and relevant clinical, electrocardiographic, radiological and biochemical findings
184. The increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women with ischaemic heart disease
185. Cellular mechanisms for lipid deposition in atherosclerosis
186. Cellular mechanisms for lipid deposition in atherosclerosis
187. Predicting coronary heart disease in siblings—a multivariate assessment: The Framingham Heart Study
188. Body build and Mortality. The Framingham Study
189. Elderly hypertensive patient. Epidemiologic review
190. Primary prevention of coronary heart disease: the last 20 years
191. Binding, internalization and degradation of low density lipoprotein by normal human fibroblasts and by fibroblasts from a case of homozygous familial hypercholesterolemia
192. Blood glucose and atheroscerosis
193. Atherosclerosis in rhesus monkeys. V. Marked diet-induced hyper cholesterolemia with xanthomatosis and severe atherosclerosis
194. Downward trend in cardiovasculazr mortality
195. Risk factors for myocardial infarction and death due to ischemic heart disease and other causes
196. A multivariate analysis of the risk of coronary heart disease in Framingham
197. Estimation of the probability of an event as a function of several independent variables
198. When the pill causes a rise in blood pressure
199. Development of the atherosclerotic plaque
200. Progression and regression of atherosclerotic lesions
201. Regression of atherosclerosis in experimental animals and man
202. Asymptomatic carotid bruit and risk of stroke The Framingham Study
203. Plasma lipoprotein distributions in male and female runners
204. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10,000 men
205. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii